Immediate Impact
51 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Sarah Cross being referenced
Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547
2016
EGFR/HER-Targeted Therapeutics In Ovarian Cancer
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sarah Cross | 91 | 40 | 123 | 104 | 32 | 398 | |
| Yukiyo Kumazawa | 68 | 21 | 104 | 128 | 32 | 376 | |
| Shaima M. Almasry | 105 | 59 | 83 | 99 | 23 | 363 | |
| Z Hájek | 103 | 29 | 88 | 113 | 37 | 342 | |
| Raffaella Cioffi | 63 | 51 | 83 | 137 | 43 | 458 | |
| Piotr Pierzyński | 105 | 11 | 100 | 124 | 25 | 398 | |
| Vincent Tricomi | 79 | 31 | 109 | 107 | 34 | 383 | |
| Thomas Laml | 56 | 39 | 105 | 154 | 25 | 428 | |
| Zarqa Saif | 129 | 23 | 192 | 105 | 21 | 401 | |
| D. R. Knab | 117 | 47 | 49 | 63 | 25 | 393 | |
| Xiaohua Liu | 75 | 56 | 47 | 48 | 33 | 430 |
All Works
Login with ORCID to disown or claim papers
Loading papers...